This inventor holds 24 USPTO granted patents and 20 published patent applications, plus 5 CIPO patents and 15 EPO patents, primarily in Pharmaceutical Innovations. Top assignees: Sichuan University, Changzhou Yinsheng Pharmaceutical Co., Ltd., Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2015-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Wuhou District Chengdu, CN (2015)
- Chengdu, CN (2015 - 2023)
- Sichuan, CN (2017 - 2023)
- Chengdu Tianfu International Bio-Town, CN (2023)
Company Filing History:
13 out of 262 
2 out of 2 
2 out of 32 
Years Active: 2015-2026
Areas of Expertise:
Title: **Yuquan Wei: A Pioneer in Biotechnology Innovations**
Introduction
Yuquan Wei, an accomplished inventor based in Chengdu, China, has made significant contributions to the field of biotechnology, with an impressive portfolio of 16 patents. His work focuses on innovative solutions in molecular biology and cancer detection, showcasing his ability to address complex technical challenges in health and disease.
Latest Patents
One of Yuquan Wei's notable inventions is the "Transmembrane Nanopore with Nucleic Acid Unwinding Function and Its Construction Methods and Applications." This invention pertains to a mutant double-strand DNA helicase protein nanopore derived from bovine papillomavirus. It addresses a key limitation of existing small-diameter protein nanopores, which typically require external forces for dsDNA transport. By providing a truncated E1-1 (306-577) protein and an E1-2 (306-605) protein, as well as their variants, this invention offers a novel solution and represents a significant advancement in the field.
Additionally, Wei has developed methods for detecting an EML4-ALK fusion tumor biomarker, particularly beneficial for patients suffering from non-small cell lung cancer. This invention details the use of a specific circular RNA found in the blood of such patients, which serves as a reliable biomarker for tumor detection. The circular RNA demonstrates high specificity and stability in plasma samples, paving the way for improved diagnostic methods through the development of specialized tumor detection kits.
Career Highlights
Yuquan Wei has had a distinguished career, primarily associated with prestigious institutions such as Sichuan University and Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. His work has not only contributed to innovative solutions in biotechnology but also to the understanding of genetic markers in cancer research.
Collaborations
Wei has collaborated closely with colleagues such as Lijuan Chen and Shengyong Yang. These partnerships have played a vital role in advancing his research efforts, fostering a collaborative environment that promotes innovation and knowledge exchange in biotechnology.
Conclusion
Yuquan Wei's contributions to the field of biotechnology, particularly in the development of innovative nanopores and tumor biomarkers, underline the importance of research and invention in addressing critical health challenges. With a strong track record of patents and collaborations, he continues to influence the landscape of biotechnology and improve diagnostic techniques for cancer detection. His work reflects the essence of innovation and the impactful role of inventors in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile